CLDF Title
Home | Contact Us | Bookmark
  HBV   HCC   HCV   HE   NASH   PBC   OTHER
About CLDF Centers of Educational Expertise  
Live CME Meetings Webcasts Slide Library Abstract Library Conference Highlights
 

Live CME Meetings

Beginning Date

06/20/2018

Ending Date

06/20/2019

1.5

credits

Target Audience

This educational program is targeted at physicians and other healthcare providers who specialize in the management of patients with substance use disorders.

Educational Objectives

Upon completion of this activity, the participants should be bettert able to:

  • Examine data on the prevalence and transmission of the hepatitis C virus (HCV) in the substance use disorder (SUD) population.
  • Describe the damaging effects of chronic HCV, thereby emphasizing the need for screening, diagnosis and treatment
  • Review data on the benefits of treating HCV patients with SUDs, with and without concomitant opioid replacement therapy
  • Discuss methods to reduce reinfection
  • Analyze ways to expand the treatment cascade and linkage to care for HCV in the SUD population
  • Identify challenges faced with regard to HCV care and treatment in SUD patients and recognize the need to prioritize the treatment of HCV in the SUD population
  • Accreditation Statement

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and the Chronic Liver Disease Foundation (CLDF). The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

    The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    The Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

    A maximum of 1.5 contact hours may be earned for successful completion of this activity.

    Disclosure of Conflicts of Interest

    All faculty and staff involved in the planning or presentation of continuing education activities sponsored/provided by the Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. Charles Willis, Director of Continuing Education, consults for Pfizer, Inc., all other staff at the Annenberg Center for Health Sciences at Eisenhower and the Chronic Liver Disease Foundation (CLDF) have no relationships to disclose.

    The opinions expressed during the live activity are those of the faculty and do not necessarily represent the views of the Annenberg Center for Health Sciences at Eisenhower. The information is presented for the purpose of advancing the attendees' professional development.

    Learner Assurance Statement

    The Annenberg Center for Health Sciences at Eisenhower is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members' significant relationships with drug or device manufacturer(s). The Annenberg Center for Health Sciences at Eisenhower is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.

    Americans with Disabilities Act

    The event staff will be glad to assist you with any special requirements (i.e. physical, dietary, etc.). Please contact us prior to the event at 888-565-5321

    For additional educational information or to register online, please visit chronicliverdisease.org.

    Accredited by:

    Provided by:

    This activity supported by:

    Educational grant from AbbVie.

    • Speaker
    • Date
    • Time
    • Venue/Location Information
    • Andrew Talal, MD, MPH
    • Monday 08/20/2018
    • 1:30 PM
    • START Treatment & Recovery - Bushwick
      Brooklyn, NY
    • Register
    • Andrew Talal, MD, MPH
    • Wednesday 08/22/2018
    • 1:30 PM
    • START Treatment & Recovery Center
      Brooklyn, NY
    • Register
    • Andrew Talal, MD, MPH
    • Thursday 08/23/2018
    • 1:30 PM
    • START Treatment & Recovery - EAST Clinic
      Brooklyn, NY
    • Register
    • Andrew Talal, MD, MPH
    • Wednesday 09/12/2018
    • 11:30 AM
    • Crouse
      Syracuse, NY
    • Register
     
                                   
     
    HBV
    Webcasts
    Slide Library
    Abstract Library
     
    HCC
    Slide Library
    Abstract Library
     
     
    HCV
    Webcasts
    Slide Library
    Abstract Library
     
     
    HE
    Webcasts
    Slide Library
    Abstract Library
     
    NASH
    Webcasts
    Slide Library
    Abstract Library
     
     
    PBC
    Webcasts
    Slide Library
    Abstract Library
     
     
    OTHER
    Webcasts
    Slide Library
       
       
     
    About CLDF
    Mission Statement
    Board of Trustees
    Board of Advisors
    CLDF Sponsors & Supporters
     
    Other Resources
    Liver News Library
    Journal Abstracts
    Hep C Link to Care
     
    Centers of
    Educational Expertise
    Hepatology
    Substance Use Disorder
                 
    CLDF Follow Us
       
      The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
    © Copyright 2012-2018 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
    Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.